Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $70.33 ($391K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $391k APGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.33 | 3,225 | $227K | 58.0% |
| 2 | $71.98 | 2,075 | $149K | 38.2% |
| 3 | $73.26 | 200 | $15K | 3.7% |
| Total | $71.06 avg | 5,500 | $391K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |